Drugs News and Research

RSS

UMass Amherst Study Shows Promise in Retraining Immune Cells for Targeting Aplastic Anemia

Researchers at the University of Massachusetts Amherst recently released a first-of-its-kind study that focuses on the rare autoimmune disorder aplastic anemia to understand how a subset of cells might be trained to correct the overzealous immune response that can lead to fatal autoimmune disorders.

28 Feb 2024

Scientists Develop First Full Model of Early Human Central Nervous System with Stem Cells

The first stem cell culture method that produces a full model of the early stages of the human central nervous system has been developed by a team of engineers and biologists at the University of Michigan, the Weizmann Institute of Science, and the University of Pennsylvania.

27 Feb 2024

Research Reveals Conserved Neutralizing Epitope in Herpesvirus gB Protein

Human herpesviruses comprise the alpha, beta, and gamma subfamilies and are a widely prevalent group of DNA-enveloped viruses, capable of establishing lifelong latent infections in humans and causing various diseases.

27 Feb 2024

Significant Increase in Antibiotic Resistance Genes Found in Humans and Livestock

Biomedical engineers at Duke University have discovered a significant connection between the dissemination of antibiotic resistance genes and the development of resistance to new drugs in specific pathogens

23 Feb 2024

Mechanism of Cancer Drug Targeting Tumor Suppressor Genes Unveiled

Researchers have revealed the mechanism of a drug shown to be effective in treating certain types of cancer, which targets a protein modification silencing the expression of multiple tumor suppressor genes.

22 Feb 2024

Uncovering How to Protect Nerves in Neurodegenerative Diseases

Researchers at the Case Western Reserve University School of Medicine have led a team that has discovered a novel therapeutic strategy for treating neurodegenerative illnesses, raising the prospect of better care for conditions like multiple sclerosis, Alzheimer's disease, Parkinson's disease, and Vanishing White Matter disease.

21 Feb 2024

The Promise of siRNA Nanomedicine for HIV Treatment

Society learned about the usefulness of mRNA during the COVID-19 pandemic when scientists and medical professionals leveraged its power to deliver a vaccine for the virus within a year.

21 Feb 2024

Investigating the Link Between Metabolism and Intestinal Development

Intestines can reach a length of 15 feet or more; how does it fit within human bodies properly? The gut tube dramatically loops and rotates to bundle the extending intestine as the digestive system grows. Intestinal malrotation is a common, but poorly understood, birth defect caused by the failure of the gut to rotate correctly during development.

20 Feb 2024

Induction Cooktop Technology Shows Promise in Reducing Bacterial Infection in Prosthetic Joints

The same technology at work in induction cooktops cut the amount of bacteria present in a prosthetic joint infection when used in conjunction with antibiotics in a mouse model, UT Southwestern Medical Center researchers report in a new study.

19 Feb 2024

ReSisTrace: Unveiling Pre-Existing Treatment Resistance in Cancer Cells

In many cancers, such as ovarian cancer, each round of chemotherapy kills the majority of cancer cells, while a small population of them survives through treatment.

14 Feb 2024

The Potential of Monoclonal Antibodies for Neonatal Herpes

The results of a recent study led by the Geisel School of Medicine and Thayer School of Engineering at Dartmouth, and published in Cell Reports Medicine, provide new information about the role that antibodies play in preventing herpes simplex virus (HSV) infections.

13 Feb 2024

Understanding T Cell Responses to Tuberculosis Infection

Researchers find promising targets for a tuberculosis vaccine and medication by monitoring T cell activity.

7 Feb 2024

Pore Power: High-Speed Droplet Production In Microfluidic Devices

Over the last two decades, ongoing research in microfluidics has faced challenges in applications due to the restricted productivity of microdroplets.

7 Feb 2024

From Lab Trials to Clinical Studies - Integrin αV's Role in Cancer Prognosis

Researchers at City of Hope, one of the biggest cancer research and treatment centers in the US, have identified a novel biological process that is critical to the pathogenic potential of cancer cells.

6 Feb 2024

Imec's Microfluidics Chip Shows Promise in Cancer Immune Profiling

The first clinical validation of Imec's cell sort chip technology has been reported in Cells through a new collaboration between Imec and the KU Leuven Laboratory of Tumor Immunology and Immunotherapy.

6 Feb 2024

Penn State Professor Receives NIH Grant to Study How Microbial Communities Impact Human Health

The bacteria and microorganisms that live within the human body -; the microbiota -; can impact human health, disease risk and even how the body absorbs medications, but the details of these processes are unclear.

6 Feb 2024

Bacteria Arrangement in Biofilm Influences Reaction to Antibiotics

Although bacteria are typically thought of as single-celled creatures suspended in liquids or dispersed sparsely across surfaces, their true mode of growth is in sticky clusters known as biofilms in many settings.

5 Feb 2024

Decoding Virus-Host Tug-of-War with RNA-Protein Interaction Mapping

The interplay between ribonucleic acid (RNA) and proteins is not only important for maintaining cellular homeostasis but is also at the center of the tug-of-war between virus and host.

2 Feb 2024

Scientists Capture Microtubule Birth in Human Cells

Researchers at the Centre for Genomic Regulation (CRG) in Barcelona and the Spanish National Cancer Research Centre (CNIO) in Madrid have captured the world's first high-resolution images of the earliest moments of microtubule formation inside human cells.

2 Feb 2024

Scientists Develop Green Antibiotic Alternative to Treat Deadly Pathogen in Hybrid Striped Bass

Scientists at the United States Department of Agriculture (USDA)'s Agricultural Research Service (ARS) developed a green antibiotic alternative to treat the deadly pathogen Streptococcus iniae in hybrid striped bass, the fourth most farmed finfish in the United States, according to a recent study.

31 Jan 2024